Subcategories:

Sort by:

select Language:



Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income Countries

G. Williams, E. Alarcón, S. Jittimanee et al., Eds.: The International Union Against Tuberculosis and Lung Disease, (2017)


2nd edition. The practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide
https://www.theunion.org/what-we-do/publications/t...


Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children. Policy brief

World Health Organization WHO, (2018)


Cryptococcal meningitis is a serious opportunistic infection which is a major cause of morbidity and mortality in people living with HIV with advanced disease, accounting for an estimated 15% of all AIDS-related deaths globally. An estimated 223,100 cases of cryptococcal meningitis result in 181,000 deaths each year among people living with HIV. Cryptococcal disease is rare in children with HIV, even in areas with a high disease burden among adults
http://apps.who.int/iris/bitstream/10665/260400/1/...


World Health Organization. Typhoid vaccines: WHO position paper.

World Health Organization WHO, (2018)


Accessed Sept, 5 2018 Weekly epidemiological record, Relevé épidémiologique hebdomadaire : Vol.93 (2018) No.13
http://apps.who.int/iris/bitstream/handle/10665/27...


Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB)

World Health Organization WHO, (2018)


The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked medicines for all patients with MDR-TB.
http://www.who.int/tb/publications/2018/WHO_RapidC...


Medicines Catalog August 2018

Global Drug Facility, Eds.: World Health Organization WHO, Stop TB, (2018)


The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
http://stoptb.org/assets/documents/gdf/Medicines_C...


API Recommendations for the Management of Typhoid Fever

Rajesh Upadhyay, Milind Y Nadkar, A Muruganathan, (2015)


Journal of The Association of Physicians of India, Vol. 63 November 2015,, pp.77-96
http://www.japi.org/november_2015/16_apir_api_reco...


Diagnostics Catalog August 2018

Global Drug Facility , Eds.: World Health Organization WHO, Stop TB, (2018)


Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
http://stoptb.org/assets/documents/gdf/Diagnostics...


Guidelines for the Diagnosis and Treatment of Malaria in Somalia

Federal Government of Somalia, Puntland & Somaliland, Zonal NMCPs/MoH, (2016)


The main objective of the malaria prevention and control programme in Somalia is to prevent mortality and reduce morbidity due to malaria. The groups most vulnerable to the disease, children aged under 5 years and pregnant women, are especially targeted. Effective case management - early diagnosis and treatment - is a critical component of malaria prevention and control. To achieve the main objective of reducing malaria morbidity and prevention of malaria mortality, the availability of safe, effective, affordable and accessible anti-malarial drugs is a prerequisite.
https://www.humanitarianresponse.info/sites/www.hu...


Regional action plan for viral hepatitis in South-East Asia: 2016-2021

World Health Organization (WHO), Regional Office for South-East-Asia, (2016)


With the goal of ending viral hepatitis as a public health threat by 2030, the Regional Action Plan will provide an actionable framework for implementing evidence-based interventions at scale. It will be informed through strategic monitoring of the response, that must be equitable and sustainable and allow for innovations for acceleration and reaching out to all in need with health services. A major reduction in prices of newer drugs to potentially cure hepatitis C offers an added opportunity to work towards its elimination.
http://www.searo.who.int/entity/hepatitis/viral-he...


329 hits